Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

ISRG

Intuitive Surgical Inc

Apr 30 • 03:15PM ET

372.69

Dollar change -1.45
Percentage change -0.39	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VOO QQQ IVV VUG IHI VHT IWF QQQM BOTZ

Index	NDX, S&P 500	P/E	67.25	EPS (ttm)	5.54	Insider Own	0.68%	Shs Outstand	352.30M	Perf Week	-1.16%
Market Cap	132.20B	Forward P/E	50.64	EPS next Y	7.36	Insider Trans	-10.80%	Shs Float	352.28M	Perf Month	-5.62%
Income	1.99B	PEG	5.35	EPS next Q	1.54	Inst Own	85.29%	Short Float	0.91%	Perf Quarter	-1.22%
Sales	7.32B	P/S	18.06	EPS this Y	9.97%	Inst Trans	-0.44%	Short Ratio	2.11	Perf Half Y	43.91%
Book/sh	39.36	P/B	9.47	EPS next Y	17.21%	ROA	13.76%	Short Interest	3.22M	Perf Year	23.73%
Cash/sh	13.53	P/C	27.54	EPS next 5Y	12.56%	ROE	15.79%	52W Range	254.85 - 403.76	Perf YTD	10.47%
Dividend Est.	-	P/FCF	646.44	EPS past 5Y	9.71%	ROI	14.24%	52W High	-7.69%	Beta	1.39
Dividend TTM	-	Quick Ratio	4.61	Sales past 5Y	14.41%	Gross Margin	66.41%	52W Low	46.24%	ATR (14)	9.30
Dividend Ex-Date	-	Current Ratio	5.55	EPS Y/Y TTM	52.08%	Oper. Margin	25.26%	RSI (14)	42.59	Volatility	2.45% 2.58%
Employees	13676	Debt/Eq	0.00	Sales Y/Y TTM	13.81%	Profit Margin	27.16%	Recom	2.00	Target Price	425.36
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	51.45%	Payout	0.00%	Rel Volume	0.40	Prev Close	374.14
Sales Surprise	1.09%	EPS Surprise	5.89%	Sales Q/Q	11.46%	Earnings	Apr 18 AMC	Avg Volume	1.52M	Price	372.69
SMA20	-1.78%	SMA50	-3.37%	SMA200	11.61%	Trades		Volume	537,998	Change	-0.39%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-17-23	Initiated	HSBC Securities	Buy	$318
Jul-19-23	Initiated	Robert W. Baird	Outperform	$377
Apr-19-23	Reiterated	Wells Fargo	Overweight	$289 → $310
Apr-19-23	Reiterated	Truist	Buy	$300 → $325
Apr-19-23	Reiterated	Stifel	Buy	$285 → $315
Apr-19-23	Reiterated	RBC Capital Mkts	Outperform	$305 → $309
Apr-19-23	Reiterated	Raymond James	Outperform	$270 → $323
Apr-19-23	Reiterated	Morgan Stanley	Equal-Weight	$265 → $285
Apr-19-23	Reiterated	JP Morgan	Overweight	$250 → $335
Apr-19-23	Reiterated	Evercore ISI	In-line	$240 → $270
Apr-19-23	Reiterated	Citigroup	Buy	$305 → $317
Apr-19-23	Reiterated	BTIG Research	Buy	$284 → $313
Apr-19-23	Reiterated	BofA Securities	Buy	$300 → $315
Mar-29-23	Initiated	UBS	Neutral	$278
Mar-23-23	Initiated	William Blair	Outperform
Oct-18-22	Initiated	Barclays	Overweight	$235
Oct-13-22	Initiated	Mizuho	Neutral	$215
Oct-12-22	Initiated	Jefferies	Hold	$210
Apr-13-22	Initiated	Truist	Buy	$360
Apr-06-22	Initiated	Wolfe Research	Peer Perform	$315

Show Previous Ratings

Today 01:44PM	Intuitive Surgical Insider Sold Shares Worth $695,293, According to a Recent SEC Filing (MT Newswires)
Apr-29-24 05:07PM	Cutting Edge Picks: 3 Med Tech Stocks With Room to Run (InvestorPlace)
Apr-26-24 02:19PM	3 Robotics Stocks That Will Make Early Investors Exceedingly Wealthy (InvestorPlace)
Apr-25-24 07:15PM	Intuitive Announces Board of Directors Elections and Retirements (GlobeNewswire)
Apr-24-24 02:26PM	Intuitive Surgical Insider Sold Shares Worth $741,398, According to a Recent SEC Filing (MT Newswires)
11:16AM	Loading…
11:16AM	Here's Why Boston Scientific Corporation (BSX) Rose in Q1 (Insider Monkey)
Apr-23-24 11:07AM	Intuitive Surgical (ISRG) Rose on its Announcement of Launch of a New Robotic System (Insider Monkey)
Apr-22-24 09:00AM	Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Apr-20-24 01:03AM	Decoding Intuitive Surgical Inc (ISRG): A Strategic SWOT Insight (GuruFocus.com)
Apr-19-24 04:13PM	Intuitive Surgical Reverses Lower On Expected 'Choppiness' For Its Pivotal Launch (Investor's Business Daily)
03:13PM	Hop on the Robotics Rocket: 3 Stocks on Pace to Triple by 2030 (InvestorPlace)
10:55AM	Intuitive Surgical, Inc. (NASDAQ:ISRG) Q1 2024 Earnings Call Transcript (Insider Monkey)
10:08AM	Intuitive Surgical Stock Pops After Selling Eight New Robots In Two Weeks (Investor's Business Daily)
08:15AM	Got $500? 3 Healthcare Stocks to Buy and Hold Forever (Motley Fool)
07:59AM	Intuitive Surgical (ISRG) Q1 Earnings Beat, Procedures Robust (Zacks)
07:00AM	Loading…
07:00AM	Q1 2024 Intuitive Surgical Inc Earnings Call (Thomson Reuters StreetEvents)
07:00AM	Intuitives rollout of new da Vinci 5 robot steals Q1 spotlight (MedTech Dive)
03:08AM	Intuitive Surgical Inc (ISRG) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and ... (GuruFocus.com)
Apr-18-24 09:46PM	Intuitive Surgical Stock Jumps After Q1 Earnings Beat Amid da Vinci Robotic System Growth (Investopedia)
09:15PM	Intuitive Surgical (ISRG) Q1 2024 Earnings Call Transcript (Motley Fool)
08:53PM	ISRG Stock Earnings: Intuitive Surgical Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:00PM	Intuitive Surgical (ISRG) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:15PM	Intuitive Surgical, Inc. (ISRG) Q1 Earnings and Revenues Top Estimates (Zacks)
04:53PM	Intuitive Surgical Pops On Quick Uptake For Its New Robotic Surgeon (Investor's Business Daily)
04:52PM	Medical device maker Intuitive beats estimates on strong demand for surgical robots (Reuters)
04:17PM	Intuitive Surgical Narrowly Beats First-Quarter Expectations, But Shares Remain Muted (Investor's Business Daily)
04:05PM	Intuitive Announces First Quarter Earnings (GlobeNewswire)
Apr-17-24 05:00PM	Robotics Stocks to Watch in April: 3 Top Picks Poised for Explosive Growth (InvestorPlace)
08:32AM	Should You Buy Intuitive Surgical (ISRG) Ahead of Earnings? (Zacks)
Apr-16-24 02:04PM	Is a Beat Likely for Intuitive Surgical (ISRG) in Q1 Earnings? (Zacks)
09:30AM	Loading…
09:30AM	Is Intuitive Surgical (ISRG) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
Apr-15-24 09:19AM	Intuitive Surgical (ISRG) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
Apr-14-24 09:30AM	What To Expect in the Markets This Week (Investopedia)
Apr-12-24 06:30AM	Wall Street Favorites: 3 Robotics Stocks with Strong Buy Ratings for April 2024 (InvestorPlace)
Apr-11-24 02:55PM	The 3 Most Promising MedTech Stocks to Invest In Now (InvestorPlace)
10:00AM	Intuitive Surgical, Inc. (ISRG) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Apr-10-24 05:30PM	If You Can Only Buy One Robotics Stock in April, It Better Be One of These 3 Names (InvestorPlace)
09:21AM	Is Intuitive Surgical Stock Going to $430? 1 Wall Street Analyst Thinks So. (Motley Fool)
09:00AM	Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
04:35AM	2 Monster Growth Stocks to Buy in 2024 Before They Surge Even Higher (Motley Fool)
Apr-09-24 06:00PM	Why Intuitive Surgical, Inc. (ISRG) Outpaced the Stock Market Today (Zacks)
Apr-04-24 10:52AM	Intuitive Surgical Stock Has 20% Upside, According to 1 Wall Street Analyst. Is the Stock a Buy Near Its All-Time High? (Motley Fool)
10:30AM	The 3 Most Undervalued Robotics Stocks to Buy in April 2024 (InvestorPlace)
Apr-03-24 06:00PM	Intuitive Surgical, Inc. (ISRG) Outperforms Broader Market: What You Need to Know (Zacks)
Apr-02-24 07:45AM	Meta Platforms, AMD Lead 10 Stocks Showing This Bullish Action (Investor's Business Daily)
07:04AM	Outperforming ETF manager names a potential 50-bagger in the stock market (MarketWatch)
Apr-01-24 02:37PM	The 3 Best Robotics Stocks to Buy in April 2024 (InvestorPlace)
12:10PM	Will Intuitive Surgical (ISRG) Beat Estimates Again in Its Next Earnings Report? (Zacks)
06:22AM	The 3 Best Robotics Stocks to Buy in Q2 2024 (InvestorPlace)
04:30AM	Meet The "Magnificent Seven" of Healthcare Stocks (Motley Fool)
Mar-31-24 07:45AM	2 Healthcare Artificial Intelligence (AI) Stocks That Could Be Smart Investment Bets (Motley Fool)
Mar-30-24 07:18AM	Is Intuitive Surgical Stock a Millionaire Maker? (Motley Fool)
Mar-29-24 09:00AM	Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Mar-28-24 02:36PM	20 Best Stocks to Buy Right Now According to Financial Media (Insider Monkey)
08:00AM	3 Healthcare Stocks to Buy From 3 of the Best Actively Managed Funds (InvestorPlace)
Mar-27-24 05:50PM	Intuitive Surgical, Inc. (ISRG) Rises But Trails Market: What Investors Should Know (Zacks)
Mar-26-24 10:42AM	Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio (Zacks)
09:30AM	Brokers Suggest Investing in Intuitive Surgical (ISRG): Read This Before Placing a Bet (Zacks)
Mar-25-24 06:00PM	Intuitive Surgical, Inc. (ISRG) Dips More Than Broader Market: What You Should Know (Zacks)
09:53AM	1 New Reason to Buy Intuitive Surgical Stock and Hold Forever (Motley Fool)
Mar-22-24 02:59PM	Hot Stocks: The 3 Best Opportunities for Retirement Investing (InvestorPlace)
09:46AM	TELA Bio, Inc. (NASDAQ:TELA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-21-24 08:45AM	1 Magnificent Growth Stock to Buy and Hold (Motley Fool)
05:06AM	3 Billionaires Are Selling Artificial Intelligence (AI) Stock Nvidia and Buying These 10 AI Stocks Instead (Motley Fool)
Mar-20-24 09:15AM	Springtime Profits: 3 Growth Stocks Poised to Bloom in March (InvestorPlace)
Mar-19-24 05:50PM	Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
02:24PM	Hot Stocks: The 3 Best Opportunities for Investing in Robotics (InvestorPlace)
Mar-18-24 04:30PM	7 Stocks That Are Making Other CEOs Lose Sleep at Night (InvestorPlace)
09:00AM	Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
05:42AM	Intuitive details launch plan for new da Vinci 5 robot (MedTech Dive)
Mar-15-24 04:11PM	Intuitive Surgical Yo-Yoes After Winning FDA Clearance For New Surgical Robot (Investor's Business Daily)
12:17PM	Adobe, Ulta Beauty fall; Madrigal, Intuitive Surgical rise, Friday, 3/15/2024 (Associated Press Finance)
10:42AM	Intuitive Surgical Pares Its Gains Despite Winning FDA Clearance For New Surgical Robot (Investor's Business Daily)
10:09AM	Intuitive Surgical's (ISRG) Da Vinci 5 Receives FDA Approval (Zacks)
09:41AM	ISRG Stock Alert: The FDA Is Giving Intuitive Surgical a Big Boost (InvestorPlace)
Mar-14-24 05:16PM	Intuitive Surgical Pops After Winning FDA Clearance For Next-Gen Robotic System (Investor's Business Daily)
04:30PM	Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5 (GlobeNewswire)
09:39AM	The Blue-Chip Advantage: 7 Stocks for Investors Who Play to Win (InvestorPlace)
Mar-13-24 05:50PM	Intuitive Surgical, Inc. (ISRG) Declines More Than Market: Some Information for Investors (Zacks)
Mar-12-24 03:00PM	Intuitive Surgical Inc EVP & Chief Strategy & Corporate Operations Officer Robert ... (GuruFocus.com)
Mar-09-24 02:11PM	Wall Street Picked These 13 AI Stocks for 2024 (Insider Monkey)
08:03AM	12 Best AI ETFs To Invest In 2024 (Insider Monkey)
Mar-06-24 01:31PM	The Top 3 Robotics Stocks to Buy in March 2024 (InvestorPlace)
11:56AM	15 Countries with the Best Public Health Systems in the World (Insider Monkey)
09:00AM	Investors Heavily Search Intuitive Surgical, Inc. (ISRG): Here is What You Need to Know (Zacks)
07:11AM	Analyst Report: Intuitive Surgical, Inc. (Morningstar Research)
Mar-05-24 06:05PM	The Top 3 Stocks for Beginners With Little Money in March 2024 (InvestorPlace)
Mar-04-24 05:50PM	Intuitive Surgical, Inc. (ISRG) Advances While Market Declines: Some Information for Investors (Zacks)
Mar-03-24 10:15AM	Adding $1,000 to These Top Growth Stocks Would Be a Brilliant Move (Motley Fool)
Mar-02-24 12:42AM	Intuitive Surgical Inc (ISRG) EVP & Chief Medical Officer Myriam Curet Sells Company Shares (GuruFocus.com)
Feb-29-24 04:08PM	3 Value Tech Stocks Ripe for the Picking (InvestorPlace)
Feb-27-24 05:50PM	Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know (Zacks)
Feb-26-24 04:54PM	3 Breakout Stocks to Buy BEFORE They Take Flight (InvestorPlace)
01:43AM	Automation Aces: 3 Top Robotics Stocks to Command Your Portfolio (InvestorPlace)
Feb-25-24 02:10PM	3 Robotics Stocks That Could Be Multibaggers in the Making: February Edition (InvestorPlace)
08:35AM	2 Unparalleled Growth Stocks That Are Smart Buys Right Now (Motley Fool)
Feb-23-24 09:30AM	Wall Street Bulls Look Optimistic About Intuitive Surgical, Inc. (ISRG): Should You Buy? (Zacks)
09:00AM	Here is What to Know Beyond Why Intuitive Surgical, Inc. (ISRG) is a Trending Stock (Zacks)
Feb-22-24 11:30AM	Why Is Intuitive Surgical, Inc. (ISRG) Up 2.8% Since Last Earnings Report? (Zacks)
06:45AM	2 Monster Stocks to Buy Without Any Hesitation (Motley Fool)

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DeSantis Robert	EVP & Chief Strategy & Corp Op	Apr 29 '24	Option Exercise	249.61	376	93,855	5,695	Apr 30 01:36 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Apr 29 '24	Sale	375.39	376	141,147	5,507	Apr 30 01:36 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Apr 26 '24	Option Exercise	273.00	1,498	408,950	5,903	Apr 30 01:36 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Apr 26 '24	Sale	369.92	1,498	554,146	5,507	Apr 30 01:36 PM
Reed Monica P	Director	Apr 25 '24	Option Exercise	0.00	569	0	1,606	Apr 26 02:47 PM
LEVY ALAN J	Director	Apr 25 '24	Option Exercise	0.00	569	0	25,888	Apr 26 02:38 PM
BARRATT CRAIG H	Director	Apr 25 '24	Option Exercise	0.00	804	0	26,155	Apr 26 02:57 PM
Beery Joseph C	Director	Apr 25 '24	Option Exercise	0.00	569	0	2,371	Apr 26 03:09 PM
Leonard Keith R	Director	Apr 25 '24	Option Exercise	0.00	569	0	1,606	Apr 26 03:44 PM
Ladd Amy L	Director	Apr 25 '24	Option Exercise	0.00	569	0	1,271	Apr 26 04:12 PM
Johnson Amal M	Director	Apr 25 '24	Option Exercise	0.00	569	0	12,275	Apr 26 05:03 PM
KANIA DON R	Director	Apr 25 '24	Option Exercise	0.00	569	0	3,838	Apr 26 08:08 PM
Kolli Sreelakshmi	Director	Apr 25 '24	Option Exercise	0.00	240	0	240	Apr 26 08:34 PM
NACHTSHEIM JAMI K	Director	Apr 25 '24	Option Exercise	0.00	569	0	5,632	Apr 26 08:41 PM
RUBASH MARK J	Director	Apr 25 '24	Option Exercise	0.00	569	0	16,051	Apr 29 05:15 PM
Curet Myriam	EVP & Chief Medical Officer	Apr 23 '24	Option Exercise	180.27	5,318	958,650	3,116	Apr 24 01:18 PM
LEVY ALAN J	Director	Apr 23 '24	Option Exercise	154.24	2,000	308,473	27,319	Apr 24 02:22 PM
Curet Myriam	EVP & Chief Medical Officer	Apr 23 '24	Sale	370.66	5,318	1,971,160	298	Apr 24 01:18 PM
LEVY ALAN J	Director	Apr 23 '24	Sale	370.70	2,000	741,398	25,319	Apr 24 02:22 PM
Widman Fredrik	VP Corporate Controller	Mar 15 '24	Option Exercise	59.23	1,224	72,495	722	Mar 18 02:35 PM
Widman Fredrik	VP Corporate Controller	Mar 15 '24	Sale	397.07	5,041	2,001,630	110	Mar 18 02:35 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Mar 11 '24	Option Exercise	243.03	329	79,956	5,627	Mar 11 08:11 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Mar 11 '24	Sale	390.16	329	128,363	5,507	Mar 11 08:11 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 11 '24	Sale	390.16	196	76,471	1,058	Mar 11 04:43 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Mar 08 '24	Option Exercise	297.63	14,728	4,383,438	18,224	Mar 11 08:11 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Mar 08 '24	Sale	393.80	20,296	7,992,510	5,507	Mar 11 08:11 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 08 '24	Sale	392.02	196	76,836	1,254	Mar 11 04:43 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 07 '24	Sale	393.30	196	77,087	1,450	Mar 07 05:17 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 06 '24	Sale	386.76	196	75,805	1,646	Mar 07 05:17 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Mar 05 '24	Sale	400.00	196	78,400	1,842	Mar 07 05:17 PM
Curet Myriam	EVP & Chief Medical Officer	Mar 01 '24	Sale	383.48	1,605	615,485	298	Mar 01 06:11 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 29 '24	Option Exercise	0.00	3,256	0	3,045	Feb 29 05:00 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Feb 29 '24	Option Exercise	0.00	3,676	0	11,772	Feb 29 05:16 PM
Rosa David J.	President	Feb 29 '24	Option Exercise	0.00	3,757	0	218,555	Feb 29 01:18 PM
Widman Fredrik	VP Corporate Controller	Feb 29 '24	Option Exercise	0.00	1,317	0	4,094	Feb 29 01:04 PM
Samath Jamie	Chief Financial Officer	Feb 29 '24	Option Exercise	0.00	2,006	0	9,139	Feb 29 07:48 PM
GUTHART GARY S	CEO	Feb 29 '24	Option Exercise	0.00	6,370	0	16,629	Mar 01 01:01 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 29 '24	Option Exercise	0.00	1,843	0	2,483	Feb 29 07:38 PM
Charlton Henry L	SVP & Chief Commercial and Mkt	Feb 29 '24	Option Exercise	0.00	2,201	0	23,824	Feb 29 06:56 PM
Miller Brian Edward	EVP & Chief Digital Officer	Feb 29 '24	Option Exercise	0.00	2,817	0	13,028	Feb 29 07:26 PM
MOHR MARSHALL	Executive VP Global Business S	Feb 29 '24	Option Exercise	0.00	3,256	0	50,150	Feb 29 07:17 PM
MOHR MARSHALL	Executive VP Global Business S	Feb 28 '24	Option Exercise	142.35	129,810	18,478,437	58,397	Feb 29 07:17 PM
MOHR MARSHALL	Executive VP Global Business S	Feb 28 '24	Sale	385.08	108,790	41,893,066	26,877	Feb 29 07:17 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 27 '24	Sale	386.46	843	325,786	298	Feb 27 03:58 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Feb 26 '24	Option Exercise	0.00	1,587	0	9,597	Feb 27 06:34 PM
GUTHART GARY S	CEO	Feb 26 '24	Option Exercise	0.00	3,030	0	13,754	Feb 26 07:38 PM
Samath Jamie	Chief Financial Officer	Feb 26 '24	Option Exercise	0.00	1,284	0	8,197	Feb 27 03:26 PM
Rosa David J.	President	Feb 26 '24	Option Exercise	0.00	1,710	0	216,807	Feb 27 03:19 PM
MOHR MARSHALL	Executive VP Global Business S	Feb 26 '24	Option Exercise	0.00	1,710	0	27,744	Feb 27 03:35 PM
Miller Brian Edward	EVP & Chief Digital Officer	Feb 26 '24	Option Exercise	0.00	1,650	0	11,432	Feb 27 03:49 PM
Widman Fredrik	VP Corporate Controller	Feb 26 '24	Option Exercise	0.00	609	0	3,298	Feb 27 01:19 PM
Charlton Henry L	SVP & Chief Commercial and Mkt	Feb 26 '24	Option Exercise	0.00	1,284	0	22,649	Feb 26 01:35 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 26 '24	Option Exercise	0.00	1,710	0	2,008	Feb 27 03:58 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 26 '24	Option Exercise	0.00	855	0	1,564	Feb 27 04:16 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 16 '24	Sale	378.29	32	12,105	709	Feb 16 05:51 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 15 '24	Sale	382.03	30	11,461	741	Feb 16 05:51 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 14 '24	Sale	380.09	30	11,403	771	Feb 16 05:51 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 13 '24	Sale	375.50	30	11,265	801	Feb 13 06:27 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 12 '24	Sale	386.09	481	185,709	298	Feb 13 12:29 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 12 '24	Sale	386.09	30	11,583	831	Feb 13 06:27 PM
Curet Myriam	EVP & Chief Medical Officer	Feb 10 '24	Option Exercise	0.00	838	0	1,136	Feb 13 12:29 PM
Widman Fredrik	VP Corporate Controller	Feb 10 '24	Option Exercise	0.00	568	0	2,911	Feb 12 02:11 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Feb 10 '24	Option Exercise	0.00	958	0	8,326	Feb 12 02:04 PM
GUTHART GARY S	CEO	Feb 10 '24	Option Exercise	0.00	2,634	0	12,059	Feb 12 03:38 PM
Samath Jamie	Chief Financial Officer	Feb 10 '24	Option Exercise	0.00	1,078	0	7,314	Feb 12 03:29 PM
Charlton Henry L	SVP & Chief Commercial and Mkt	Feb 10 '24	Option Exercise	0.00	1,078	0	21,703	Feb 12 01:55 PM
MOHR MARSHALL	Executive VP Global Business S	Feb 10 '24	Option Exercise	0.00	2,873	0	27,119	Feb 12 03:21 PM
Miller Brian Edward	EVP & Chief Digital Officer	Feb 10 '24	Option Exercise	0.00	1,317	0	10,269	Feb 12 04:23 PM
Brosius Mark	See Remarks	Feb 10 '24	Option Exercise	0.00	838	0	1,286	Feb 12 04:23 PM
Rosa David J.	President	Feb 10 '24	Option Exercise	0.00	1,437	0	215,826	Feb 12 04:54 PM
LOEB GARY	General Counsel	Feb 10 '24	Option Exercise	0.00	315	0	2,024	Feb 12 08:57 PM
Rosa David J.	President	Feb 07 '24	Option Exercise	52.37	140,850	7,375,967	230,089	Feb 08 02:06 PM
Rosa David J.	President	Feb 07 '24	Sale	389.28	80,710	31,418,468	163,399	Feb 08 02:06 PM
Brosius Mark	SVP & Chief Mfg and Supply Cha	Feb 01 '24	Sale	378.41	39	14,758	448	Feb 05 05:15 PM
GUTHART GARY S	CEO	Jan 29 '24	Option Exercise	51.02	33,750	1,721,776	33,750	Jan 30 04:28 PM
GUTHART GARY S	CEO	Jan 29 '24	Sale	376.06	24,325	9,147,669	9,425	Jan 30 04:28 PM
GUTHART GARY S	CEO	Jan 29 '24	Sale	374.41	4,960	1,857,074	27,360	Jan 30 04:28 PM
Curet Myriam	EVP & Chief Medical Officer	Jan 26 '24	Option Exercise	179.67	4,318	775,816	3,007	Jan 29 05:32 PM
Johnson Amal M	Director	Jan 26 '24	Option Exercise	56.97	6,696	381,501	18,402	Jan 29 05:25 PM
LEVY ALAN J	Director	Jan 26 '24	Option Exercise	92.79	2,000	185,578	27,247	Jan 29 05:28 PM
Johnson Amal M	Director	Jan 26 '24	Sale	370.08	6,696	2,478,032	11,706	Jan 29 05:25 PM
Curet Myriam	EVP & Chief Medical Officer	Jan 26 '24	Sale	370.15	4,318	1,598,298	189	Jan 29 05:32 PM
LEVY ALAN J	Director	Jan 26 '24	Sale	370.20	2,000	740,405	25,319	Jan 29 05:28 PM
Curet Myriam	EVP & Chief Medical Officer	Nov 16 '23	Option Exercise	173.01	8,819	1,525,799	4,689	Nov 17 03:00 PM
Johnson Amal M	Director	Nov 16 '23	Option Exercise	41.26	9,567	394,713	21,273	Nov 17 03:11 PM
Johnson Amal M	Director	Nov 16 '23	Sale	300.00	9,567	2,870,100	11,706	Nov 17 03:11 PM
Curet Myriam	EVP & Chief Medical Officer	Nov 16 '23	Sale	300.00	8,819	2,645,700	189	Nov 17 03:00 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Nov 14 '23	Option Exercise	244.58	867	212,054	7,856	Nov 15 06:45 PM
LEVY ALAN J	Director	Nov 14 '23	Option Exercise	90.49	2,000	180,989	27,319	Nov 15 06:44 PM
LEVY ALAN J	Director	Nov 14 '23	Sale	290.00	2,000	580,000	25,319	Nov 15 06:44 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Nov 14 '23	Sale	290.00	867	251,430	7,259	Nov 15 06:45 PM
GUTHART GARY S	CEO	Oct 26 '23	Option Exercise	49.34	33,750	1,665,336	50,936	Oct 26 07:51 PM
GUTHART GARY S	CEO	Oct 26 '23	Sale	260.11	27,385	7,123,030	23,551	Oct 26 07:51 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Oct 24 '23	Option Exercise	194.12	1,110	215,468	7,823	Oct 25 04:30 PM
GUTHART GARY S	CEO	Oct 24 '23	Sale	271.93	4,960	1,348,773	29,840	Oct 26 07:51 PM
DeSantis Robert	EVP & Chief Strategy & Corp Op	Oct 24 '23	Sale	273.49	1,110	303,574	7,259	Oct 25 04:30 PM
LOEB GARY	General Counsel	Oct 10 '23	Option Exercise	0.00	2,613	0	2,613	Oct 12 05:18 PM
Ladd Amy L	Director	Sep 14 '23	Sale	305.68	500	152,840	702	Sep 15 04:39 PM
LEVY ALAN J	Director	Aug 07 '23	Option Exercise	86.04	2,000	172,074	26,854	Aug 08 05:21 PM
LEVY ALAN J	Director	Aug 07 '23	Sale	310.00	2,000	620,000	25,319	Aug 08 05:21 PM

Open in Screener

NKTR

Nektar Therapeutics

Apr 30 • 03:15PM ET

1.45

Dollar change -0.01
Percentage change -1.03	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

NKTR Nektar Therapeutics daily Stock Chart

Held by: VTI VXF SCHA PRFZ VHT SCHB NANC

Index	-	P/E	-	EPS (ttm)	-1.46	Insider Own	3.09%	Shs Outstand	191.38M	Perf Week	1.76%
Market Cap	265.33M	Forward P/E	-	EPS next Y	-0.71	Insider Trans	-1.28%	Shs Float	177.94M	Perf Month	59.83%
Income	-276.06M	PEG	-	EPS next Q	-0.19	Inst Own	64.78%	Short Float	1.75%	Perf Quarter	158.04%
Sales	90.12M	P/S	2.94	EPS this Y	38.97%	Inst Trans	-4.28%	Short Ratio	1.23	Perf Half Y	204.98%
Book/sh	0.68	P/B	2.11	EPS next Y	19.49%	ROA	-49.80%	Short Interest	3.11M	Perf Year	92.08%
Cash/sh	1.65	P/C	0.87	EPS next 5Y	-7.30%	ROE	-110.95%	52W Range	0.41 - 1.75	Perf YTD	155.75%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-80.69%	52W High	-17.43%	Beta	0.77
Dividend TTM	-	Quick Ratio	6.14	Sales past 5Y	-20.42%	Gross Margin	62.53%	52W Low	250.22%	ATR (14)	0.14
Dividend Ex-Date	-	Current Ratio	6.45	EPS Y/Y TTM	26.08%	Oper. Margin	-150.05%	RSI (14)	60.50	Volatility	7.54% 12.91%
Employees	137	Debt/Eq	1.76	Sales Y/Y TTM	-2.10%	Profit Margin	-306.31%	Recom	3.00	Target Price	3.00
Option/Short	Yes / Yes	LT Debt/Eq	1.61	EPS Q/Q	30.53%	Payout	-	Rel Volume	0.27	Prev Close	1.46
Sales Surprise	11.47%	EPS Surprise	-4.56%	Sales Q/Q	8.45%	Earnings	Mar 04 AMC	Avg Volume	2.53M	Price	1.45
SMA20	7.20%	SMA50	39.51%	SMA200	109.22%	Trades		Volume	619,202	Change	-1.03%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-20-23	Resumed	JP Morgan	Underweight
Nov-09-23	Upgrade	TD Cowen	Market Perform → Outperform
May-10-23	Upgrade	Jefferies	Underperform → Hold	$1.50 → $1
Feb-24-23	Downgrade	Jefferies	Hold → Underperform	$3.20 → $1.50
Aug-08-22	Downgrade	JP Morgan	Neutral → Underweight
May-31-22	Resumed	Jefferies	Hold	$12 → $4
Apr-18-22	Downgrade	Goldman	Neutral → Sell	$3
Mar-15-22	Downgrade	Mizuho	Buy → Neutral	$35 → $8
Mar-15-22	Downgrade	Cowen	Outperform → Market Perform
Mar-14-22	Downgrade	William Blair	Outperform → Mkt Perform
Mar-14-22	Downgrade	Stifel	Buy → Hold	$24 → $5
Mar-14-22	Downgrade	BTIG Research	Buy → Neutral
Mar-14-22	Downgrade	BofA Securities	Neutral → Underperform	$18 → $6
Mar-09-22	Upgrade	Oppenheimer	Perform → Outperform	$21
Nov-08-21	Upgrade	The Benchmark Company	Hold → Buy	$20
Sep-10-21	Initiated	BofA Securities	Neutral	$18
Jun-28-21	Upgrade	Stifel	Hold → Buy	$22 → $24
May-18-21	Resumed	Goldman	Neutral	$24
Feb-22-21	Downgrade	The Benchmark Company	Buy → Hold
Jan-06-21	Initiated	Stifel	Hold	$18

Show Previous Ratings

Apr-03-24 11:30AM	Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue? (Zacks) +9.47%
Mar-25-24 10:00AM	DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-22-24 02:00PM	Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference (PR Newswire)
Mar-06-24 12:33PM	Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata (Zacks)
Mar-05-24 10:07AM	Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat (Zacks)
09:13AM	Loading…
09:13AM	Nektar Therapeutics (NASDAQ:NKTR) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:00AM	Nektar Therapeutics Announces Initiation of Phase 2b Clinical Study Evaluating Rezpegaldesleukin in Patients with Severe to Very Severe Alopecia Areata (PR Newswire)
07:19AM	Q4 2023 Nektar Therapeutics Earnings Call (Thomson Reuters StreetEvents)
Mar-04-24 05:30PM	Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +15.38%
04:51PM	Nektar Therapeutics (NKTR) Reports Fiscal Year-End and Q4 2023 Results (GuruFocus.com)
04:42PM	Nektar: Q4 Earnings Snapshot (Associated Press Finance)
04:15PM	Nektar Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results (PR Newswire)
08:30AM	Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX (PR Newswire)
Feb-27-24 06:00PM	Nektar Management to Present at the TD Cowen 44th Annual Health Care Conference (PR Newswire) +11.94%
Feb-26-24 06:00PM	Nektar to Announce Financial Results for the Fourth Quarter and Year-Ended 2023 on Monday, March 4, 2024, After Close of U.S.-Based Financial Markets (PR Newswire)
10:00AM	Loading…
Feb-20-24 10:00AM	Will Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Know (Zacks) -6.78%
Jan-03-24 06:00PM	Nektar Management To Present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA (PR Newswire) -6.36%
Dec-11-23 06:00PM	Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting (PR Newswire)
Dec-07-23 11:31AM	Nektar (NKTR) Up 4% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-09-23 08:39AM	Nektar Therapeutics (NASDAQ:NKTR) Q3 2023 Earnings Call Transcript (Insider Monkey) -5.00%
Nov-08-23 11:47AM	Nektar Therapeutics (NKTR) Incurs Wider-Than-Expected Q3 Loss (Zacks) -8.76%
Nov-07-23 05:28PM	Nektar: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Nektar Therapeutics Reports Third Quarter 2023 Financial Results (PR Newswire)
Oct-31-23 06:00PM	Nektar to Announce Financial Results for the Third Quarter 2023 on Tuesday, November 7, 2023, After Close of U.S.-Based Financial Markets (PR Newswire)
Oct-26-23 10:02AM	Nektar Therapeutics (NKTR) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-23-23 10:08AM	12 Best Penny Stocks to Buy Under $1 (Insider Monkey) -7.11%
Oct-13-23 08:30AM	Nektar Presents New Responder Data for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy, in Late-Breaking News Oral Presentation at 2023 EADV Congress (PR Newswire)
Oct-02-23 09:00AM	Nektar Therapeutics Announces Two Abstracts Accepted at EADV Congress 2023 for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy (PR Newswire)
Sep-27-23 09:00AM	Nektar Therapeutics Announces New Clinical Study Collaboration with Cellular Biomedicine Group Inc. to Evaluate NKTR-255 in Combination with C-TIL051 in Advanced Non-Small Cell Lung Cancer (PR Newswire)
Sep-14-23 07:54AM	Nektar (NKTR) Up on Positive New Data From Eczema Study (Zacks)
09:00AM	Loading…
Sep-13-23 09:00AM	Nektar Therapeutics Announces Promising New Data from Phase 1b Study of Rezpegaldesleukin in Moderate-to-Severe Atopic Dermatitis (PR Newswire)
Sep-07-23 11:31AM	Why Is Nektar (NKTR) Down 37.1% Since Last Earnings Report? (Zacks)
Sep-06-23 06:00PM	Nektar Therapeutics to Host Virtual Investor & Analyst Event with Dermatology Experts on September 13th (PR Newswire)
Aug-17-23 07:02PM	RA Capital Management, L.P. Acquires Significant Stake in Nektar Therapeutics (GuruFocus.com) -6.26%
Aug-09-23 09:25AM	Nektar Therapeutics (NKTR) Q2 Loss Narrows, Sales Miss (Zacks) -8.94%
Aug-08-23 05:30PM	Nektar Therapeutics (NKTR) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:23PM	Nektar: Q2 Earnings Snapshot (AP Finance)
04:15PM	Nektar Therapeutics Reports Second Quarter 2023 Financial Results (PR Newswire)
11:08AM	Nektar Therapeutics sues Lilly for breach of contract around skin drug (American City Business Journals)
Aug-07-23 10:23AM	Nektar Therapeutics sues Eli Lilly over autoimmune disease treatment (Reuters) +91.51%
06:30AM	Nektar Announces Promising New and Corrected Rezpegaldesleukin Efficacy Data Which Were Previously Reported in 2022 and Incorrectly Calculated by Former Collaborator Eli Lilly & Company (PR Newswire)
Aug-01-23 06:00PM	Nektar to Announce Financial Results for the Second Quarter 2023 on Tuesday, August 8, 2023, After Close of U.S.-Based Financial Markets (PR Newswire)
Jul-24-23 03:48AM	Zoetis (ZTS) Moves 6.9% Higher: Will This Strength Last? (Zacks) -5.69%
Jul-16-23 08:49AM	Nektar Therapeutics (NASDAQ:NKTR) is largely controlled by institutional shareholders who own 70% of the company (Simply Wall St.)
Jun-12-23 06:00PM	Nektar Therapeutics to Participate in Fireside Chat at the Goldman Sachs 44th Annual Global Healthcare Conference (PR Newswire)
Jun-08-23 12:55PM	Investors Don't See Light At End Of Nektar Therapeutics' (NASDAQ:NKTR) Tunnel (Simply Wall St.)
11:31AM	Why Is Nektar (NKTR) Down 19.7% Since Last Earnings Report? (Zacks)
May-10-23 11:28AM	Nektar Therapeutics (NASDAQ:NKTR) Q1 2023 Earnings Call Transcript (Insider Monkey)
09:16AM	Nektar Therapeutics (NKTR) Q1 Earnings & Revenues Beat (Zacks)
May-09-23 06:45PM	Nektar Therapeutics (NKTR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:41PM	Nektar: Q1 Earnings Snapshot (AP Finance)
04:15PM	Nektar Therapeutics Reports First Quarter 2023 Financial Results (PR Newswire)
May-08-23 09:29AM	Biotech Stocks' Q1 Earnings on May 9: NVAX, EBS & More (Zacks) -5.94%
May-04-23 10:00AM	Earnings Preview: Marinus Pharmaceuticals (MRNS) Q1 Earnings Expected to Decline (Zacks)
May-02-23 10:01AM	Will Nektar Therapeutics (NKTR) Report Negative Earnings Next Week? What You Should Know (Zacks)
Apr-27-23 08:30AM	Nektar Therapeutics Announces It Will Regain Full Rights to Rezpegaldesleukin (REZPEG, NKTR-358), a Novel, First-in-Class Selective Regulatory T-cell (Treg) Therapy in Clinical Development (PR Newswire)
Apr-19-23 08:38AM	Zacks.com featured highlights include Disney, Casey's General Stores, OpGen, Accelerate Diagnostics and Nektar Therapeutics (Zacks)
Apr-17-23 05:00PM	Nektar Therapeutics Announces Strategic Reprioritization and Cost Restructuring Plan (PR Newswire) +6.26%
Apr-16-23 06:30AM	7 Sorry Pharma Stocks to Sell in April Before Its Too Late (InvestorPlace)
Apr-13-23 10:59AM	Here's Why You May Add Nektar (NKTR) Stock to Your Portfolio (Zacks) +10.16%
Apr-11-23 08:57AM	Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, KalVista Pharmaceuticals, Larimar Therapeutics, Nektar Therapeutics and Jounce Therapeutics (Zacks) +10.53%
Apr-10-23 10:07AM	5 Stocks to Buy as the Drug Industry Rebounds in 2023 (Zacks) +6.57%
Apr-02-23 08:27AM	We Think Nektar Therapeutics (NASDAQ:NKTR) Needs To Drive Business Growth Carefully (Simply Wall St.)
Mar-30-23 11:30AM	Why Is Nektar (NKTR) Down 51.9% Since Last Earnings Report? (Zacks) -12.42%
Mar-29-23 05:44PM	Crane Set to Join S&P MidCap 400; PacWest Bancorp to Join S&P SmallCap 600 (PR Newswire)
Mar-24-23 12:00PM	Nektar (NKTR) Upgraded to Buy: Here's Why (Zacks)
Mar-22-23 09:35AM	Down -69.13% in 4 Weeks, Here's Why You Should You Buy the Dip in Nektar (NKTR) (Zacks) -9.73%
Mar-14-23 03:43AM	Sage Therapeutics, Inc. (SAGE) Soars 9.6%: Is Further Upside Left in the Stock? (Zacks)
Feb-28-23 05:15PM	Nektar Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results (PR Newswire)
Feb-24-23 10:23AM	Why Nektar Therapeutics Stock Is Plunging Today (Benzinga) -49.66%
07:29AM	Boeing stock slips after deliveries of 787s halted; Beyond Meat shares rally after plant-food makers results (MarketWatch)
Feb-23-23 06:20PM	UPDATE 1-Nektar Therapeutics' autoimmune disease drug fails mid-stage study (Reuters)
05:24PM	Nektar stock drops more than 30% after study involving lupus treatment will not go forward (MarketWatch)
04:30PM	Nektar Therapeutics Announces Phase 2 Topline Data for Rezpegaldesleukin in Patients with Systemic Lupus Erythematosus (PR Newswire)
Jan-09-23 09:04AM	Concert (CNCE) Moves 19.3% Higher: Will This Strength Last? (Zacks)
Jan-04-23 09:00AM	Nektar Therapeutics' President and CEO, Howard Robin, To Present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA (PR Newswire) +6.85%
Dec-12-22 10:05AM	Nektar Announces Poster Presentations at the 64th American Society of Hematology (ASH) Annual Meeting (PR Newswire)
Dec-05-22 08:00AM	Nektar Therapeutics to Host Investor & Analyst Event on December 12th (PR Newswire)
Nov-10-22 09:05AM	Nektar Therapeutics Presents Preclinical Data from Novel PEGylated Interferon Gamma Program, NKTR-288, at the Society for Immunotherapy of Cancer (SITC) Annual Meeting (PR Newswire) +8.66%
07:58AM	Nektar Therapeutics Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-09-22 09:00AM	Nektar and Collaborators Announce Publication in Blood Advances of Preclinical Data Demonstrating NKTR-255, a Novel Polymer-conjugated Human IL-15, Improves Efficacy of CD19-targeted CAR-T Cell Immunotherapy (PR Newswire) -5.54%
Nov-04-22 12:35PM	Nektar's (NKTR) Q3 Earnings and Revenues Beat Estimates (Zacks) +5.90%
Nov-03-22 06:35PM	Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
Oct-28-22 10:00AM	ImmunoGen (IMGN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Oct-27-22 10:02AM	Nektar Therapeutics (NKTR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Oct-25-22 06:00PM	Nektar to Announce Financial Results for the Third Quarter 2022 on Thursday, November 3, 2022, After Close of U.S.-Based Financial Markets (PR Newswire)
Oct-24-22 07:55AM	Here's Why We're Watching Nektar Therapeutics' (NASDAQ:NKTR) Cash Burn Situation (Simply Wall St.)
Oct-11-22 05:13PM	Why a S.F. biotech and its potential merger partner pulled the plug on talks (American City Business Journals)
Oct-07-22 03:42PM	Longtime S.F. biotech in talks with London company on 'combination' (American City Business Journals)
11:21AM	PureTech Health Confirms 'Possible' Merger With Nektar Therapeutics (Benzinga)
Sep-07-22 01:15AM	Nektar Therapeutics Presents Data for Rezpegaldesleukin (LY3471851) in Patients with Atopic Dermatitis and Psoriasis from Two Separate Clinical Studies at 2022 European Academy of Dermatology (EADV) Congress (PR Newswire)
Aug-21-22 09:57AM	Nektar Therapeutics (NASDAQ:NKTR shareholders incur further losses as stock declines 11% this week, taking five-year losses to 75% (Simply Wall St.)
Aug-16-22 08:30AM	Nektar and Collaborators Announce Preclinical Publication of Data for NKTR-255 and its Observed Improvement of NK Cell Function in Multiple Myeloma (PR Newswire)
Aug-05-22 12:11PM	Nektar's (NKTR) Q2 Earnings and Revenues Miss Estimates (Zacks) +10.41%
Aug-04-22 06:15PM	Nektar Therapeutics (NKTR) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:15PM	Nektar Therapeutics Reports Second Quarter 2022 Financial Results (PR Newswire)
Jul-26-22 06:00PM	Nektar to Announce Financial Results for the Second Quarter 2022 on Thursday, August 4, 2022, After Close of U.S.-Based Financial Markets (PR Newswire) +5.91%
Jul-14-22 06:01AM	Catalyst (CPRX) Stock Jumps 10%: Will It Continue to Soar? (Zacks)
Jul-01-22 06:30AM	Nektar Announces Promotion of Jillian B. Thomsen to Senior Vice President & Chief Financial Officer (PR Newswire)
May-27-22 08:00AM	After a record-breaking decade, biotech is discovering what hard times feel like (American City Business Journals)

Nektar Therapeutics is a research-based biopharmaceutical company which engages in discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and autoimmune diseases. The company was founded in 1990 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROBIN HOWARD W	President & CEO	Feb 20 '24	Sale	0.68	20,033	13,622	879,889	Feb 22 08:16 PM
Zalevsky Jonathan	Chief R&D Officer	Feb 20 '24	Sale	0.68	9,014	6,130	265,025	Feb 22 08:19 PM
Wilson Mark Andrew	Chief Legal Officer	Feb 20 '24	Sale	0.68	7,606	5,172	236,674	Feb 22 08:17 PM
ROBIN HOWARD W	President & CEO	Nov 17 '23	Sale	0.49	19,877	9,740	899,922	Nov 20 08:58 PM
Zalevsky Jonathan	Chief R&D Officer	Nov 17 '23	Sale	0.49	9,646	4,727	274,039	Nov 20 09:02 PM
Wilson Mark Andrew	Chief Legal Officer	Nov 17 '23	Sale	0.49	7,179	3,518	243,780	Nov 20 09:00 PM
Curet Myriam	Director	Sep 18 '23	Sale	0.69	4,359	3,008	27,418	Sep 20 08:09 PM
Ajer Jeffrey Robert	Director	Sep 18 '23	Sale	0.69	4,359	3,008	34,153	Sep 20 08:06 PM
ROBIN HOWARD W	President & CEO	Aug 16 '23	Sale	0.78	19,998	15,598	919,799	Aug 17 08:06 PM
Zalevsky Jonathan	Chief R&D Officer	Aug 16 '23	Sale	0.78	9,703	7,568	283,685	Aug 17 08:08 PM
Wilson Mark Andrew	Chief Legal Officer	Aug 16 '23	Sale	0.78	7,221	5,632	250,959	Aug 17 08:07 PM
WHITFIELD ROY A	Director	Jun 14 '23	Sale	0.57	30,000	17,100	216,250	Jun 15 06:26 PM
ROBIN HOWARD W	President & CEO	May 16 '23	Sale	0.72	20,361	14,660	939,797	May 17 08:27 PM
Zalevsky Jonathan	Chief R&D Officer	May 16 '23	Sale	0.72	9,791	7,050	293,388	May 17 08:29 PM
Wilson Mark Andrew	Chief Legal Officer	May 16 '23	Sale	0.72	7,543	5,431	257,680	May 17 08:28 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

ISRG

Intuitive Surgical Inc

NKTR

Nektar Therapeutics

Upgrade your FINVIZ experience